NASDAQ:CGNX - Cognex Stock Price, Price Target & More

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex announced a quarterly dividend on Monday, April 30th. Investors of record on Friday, May 18th will be given a dividend of $0.045 per share on Friday, June 1st. This represents a $0.18 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Thursday, May 17th. View Cognex's Dividend History.

Shares of Cognex split on the morning of Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly created shares were issued to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex announced that its Board of Directors has initiated a share repurchase plan on Friday, February 16th 2018, which permits the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

Cognex Co. (NASDAQ:CGNX) issued its earnings results on Thursday, February, 15th. The scientific and technical instruments company reported $0.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.05. The scientific and technical instruments company earned $180.37 million during the quarter, compared to analyst estimates of $178.75 million. Cognex had a net margin of 21.56% and a return on equity of 23.08%. The company's revenue for the quarter was up 39.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.20 earnings per share. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Cognex.

9 analysts have issued twelve-month price targets for Cognex's shares. Their predictions range from $40.00 to $80.00. On average, they expect Cognex's share price to reach $57.4167 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price. View Analyst Ratings for Cognex.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cognex include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Orbotech (ORBK), Esterline Technologies (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), International Isotopes (INIS) and Elbit Vision Systems (EVSNF).

Media headlines about CGNX stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cognex earned a daily sentiment score of 0.14 on Accern's scale. They also assigned news articles about the scientific and technical instruments company an impact score of 45.86 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Cognex's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include American Capital Management Inc. (0.93%), Fred Alger Management Inc. (0.70%), Handelsbanken Fonder AB (0.32%), Welch & Forbes LLC (0.24%), Riverbridge Partners LLC (0.21%) and Westpac Banking Corp (0.05%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Richard Morin, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Essex Investment Management Co. LLC, Sit Investment Associates Inc., Municipal Employees Retirement System of Michigan and Riverbridge Partners LLC. Company insiders that have sold Cognex company stock in the last year include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Insider Buying and Selling for Cognex.

CGNX stock was purchased by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Welch & Forbes LLC, Bellecapital International Ltd., DnB Asset Management AS, Pennsylvania Trust Co, Exane Derivatives, Whittier Trust Co. and Bank of Montreal Can. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $44.43.

Cognex has a market capitalization of $7.77 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]